Resonance Health Limited (ASX:RHT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0480
-0.0020 (-4.00%)
May 6, 2026, 3:58 PM AEST
Market Cap22.90M -4.2%
Revenue (ttm)13.84M +31.4%
Net Income769.30K
EPS0.00
Shares Out477.12M
PE Ratio29.50
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume594,578
Average Volume583,418
Open0.0490
Previous Close0.0500
Day's Range0.0460 - 0.0500
52-Week Range0.0330 - 0.0590
Beta1.14
RSI66.98
Earnings DateMay 27, 2026

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-bas... [Read more]

Sector Healthcare
Founded 1987
Employees 16
Stock Exchange Australian Securities Exchange
Ticker Symbol RHT
Full Company Profile

Financial Performance

Financial Statements